title: Acute Generalized Pustular Psoriasis Treated With the IL-17A Antibody Secukinumab.
authors.affiliation: Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany.
authors.forename: Alexander
authors.initials: A
authors.lastname: Böhner
authors.affiliation: Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany.
authors.forename: Sophie
authors.initials: S
authors.lastname: Roenneberg
authors.affiliation: Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany.
authors.forename: Kilian
authors.initials: K
authors.lastname: Eyerich
authors.affiliation: Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany.
authors.forename: Bernadette
authors.initials: B
authors.lastname: Eberlein
authors.affiliation: Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany.
authors.forename: Tilo
authors.initials: T
authors.lastname: Biedermann
mesh_terms: D000208:Acute Disease; D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D020381:Interleukin-17 / Q000037:antagonists & inhibitors*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C508717:IL17A protein, human; D020381:Interleukin-17; C555450:secukinumab